Financhill
Back

GeneDx Holdings 10K Form

Buy
58

WGS
GeneDx Holdings

Last Price:
$79.48
Seasonality Move:
51.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive WGS News And Ratings

See the #1 stock for the next 7 days that we like better than WGS

WGS Financial Statistics

Sales & Book Value

Annual Sales: $202.6M
Cash Flow: $-5M
Price / Cash Flow: 0
Annual Sales: $7.45
Price / Book: 10.4

Profitability

EPS (TTM): -3.11000
Net Income (TTM): $-83.5M
Gross Margin: $90M
Return on Equity: -38.37%
Return on Assets: -20.58%

GeneDx Holdings Earnings Forecast

Key GeneDx Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for WGS is 44.43%.
  • The Selling, General & Administrative Expenses for WGS have been equal to 96.12% of Gross Profit Margin.
  • The Research & Development expenses have been 28.76% of Revenue.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of WGS is -86.77% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

GeneDx Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: WGS
Website: genedx.com

Debt

Debt-to-Equity Ratio: 0.25
Current Ratio: 2.41
Quick Ratio: 2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 157.96

WGS Technical Analysis vs Fundamental Analysis

Buy
58
GeneDx Holdings (WGS) is a Buy

Is GeneDx Holdings a Buy or a Sell?

  • GeneDx Holdings stock is rated a Buy
    The current GeneDx Holdings [WGS] share price is $77.40. The Score for WGS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.